Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Harvard Business School
AstraZeneca
Dow
Johnson and Johnson

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Details for Biologics License Application: 125274

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for BLA: 125274
Tradename:DYSPORT
Applicant:Ipsen Biopharm Ltd
Ingredient:abobotulinumtoxina
Patents:8
Approval Date:Apr 29, 2009
Suppliers: see list2
Pharmacology for BLA: 125274

US Patents for BLA: 125274

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Ipsen Biopharm Ltd DYSPORT abobotulinumtoxina INJECTABLE; INJECTION 125274 001 2009-04-29   Start Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2033-03-11 RX search
Ipsen Biopharm Ltd DYSPORT abobotulinumtoxina INJECTABLE; INJECTION 125274 001 2009-04-29   Start Trial Allergan, Inc. (Irvine, CA) 2030-03-30 RX search
Ipsen Biopharm Ltd DYSPORT abobotulinumtoxina INJECTABLE; INJECTION 125274 001 2009-04-29   Start Trial 2039-03-29 RX search
Ipsen Biopharm Ltd DYSPORT abobotulinumtoxina INJECTABLE; INJECTION 125274 001 2009-04-29   Start Trial 2030-10-23 RX search
Ipsen Biopharm Ltd DYSPORT abobotulinumtoxina INJECTABLE; INJECTION 125274 001 2009-04-29   Start Trial Allergan, Inc. (Irvine, CA) 2030-03-30 RX search
Ipsen Biopharm Ltd DYSPORT abobotulinumtoxina INJECTABLE; INJECTION 125274 001 2009-04-29   Start Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2033-03-11 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Moodys
Merck
Medtronic
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.